240 related articles for article (PubMed ID: 24249112)
1. Langerhans cells are generated by two distinct PU.1-dependent transcriptional networks.
Chopin M; Seillet C; Chevrier S; Wu L; Wang H; Morse HC; Belz GT; Nutt SL
J Exp Med; 2013 Dec; 210(13):2967-80. PubMed ID: 24249112
[TBL] [Abstract][Full Text] [Related]
2. Differential involvement of PU.1 and Id2 downstream of TGF-beta1 during Langerhans-cell commitment.
Heinz LX; Platzer B; Reisner PM; Jörgl A; Taschner S; Göbel F; Strobl H
Blood; 2006 Feb; 107(4):1445-53. PubMed ID: 16223775
[TBL] [Abstract][Full Text] [Related]
3. Establishing and maintaining the Langerhans cell network.
Chopin M; Nutt SL
Semin Cell Dev Biol; 2015 May; 41():23-9. PubMed ID: 24513231
[TBL] [Abstract][Full Text] [Related]
4. Two distinct types of Langerhans cells populate the skin during steady state and inflammation.
Seré K; Baek JH; Ober-Blöbaum J; Müller-Newen G; Tacke F; Yokota Y; Zenke M; Hieronymus T
Immunity; 2012 Nov; 37(5):905-16. PubMed ID: 23159228
[TBL] [Abstract][Full Text] [Related]
5. Genomic programming of IRF4-expressing human Langerhans cells.
Sirvent S; Vallejo AF; Davies J; Clayton K; Wu Z; Woo J; Riddell J; Chaudhri VK; Stumpf P; Nazlamova LA; Wheway G; Rose-Zerilli M; West J; Pujato M; Chen X; Woelk CH; MacArthur B; Ardern-Jones M; Friedmann PS; Weirauch MT; Singh H; Polak ME
Nat Commun; 2020 Jan; 11(1):313. PubMed ID: 31949143
[TBL] [Abstract][Full Text] [Related]
6. Aryl hydrocarbon receptor activation inhibits in vitro differentiation of human monocytes and Langerhans dendritic cells.
Platzer B; Richter S; Kneidinger D; Waltenberger D; Woisetschläger M; Strobl H
J Immunol; 2009 Jul; 183(1):66-74. PubMed ID: 19535631
[TBL] [Abstract][Full Text] [Related]
7. PU.1 cooperates with IRF4 and IRF8 to suppress pre-B-cell leukemia.
Pang SH; Minnich M; Gangatirkar P; Zheng Z; Ebert A; Song G; Dickins RA; Corcoran LM; Mullighan CG; Busslinger M; Huntington ND; Nutt SL; Carotta S
Leukemia; 2016 Jun; 30(6):1375-87. PubMed ID: 26932576
[TBL] [Abstract][Full Text] [Related]
8. PU.1, interferon regulatory factor (IRF) 2, and the interferon consensus sequence-binding protein (ICSBP/IRF8) cooperate to activate NF1 transcription in differentiating myeloid cells.
Huang W; Horvath E; Eklund EA
J Biol Chem; 2007 Mar; 282(9):6629-43. PubMed ID: 17200120
[TBL] [Abstract][Full Text] [Related]
9. Positive regulatory domain I (PRDM1) and IRF8/PU.1 counter-regulate MHC class II transactivator (CIITA) expression during dendritic cell maturation.
Smith MA; Wright G; Wu J; Tailor P; Ozato K; Chen X; Wei S; Piskurich JF; Ting JP; Wright KL
J Biol Chem; 2011 Mar; 286(10):7893-7904. PubMed ID: 21216962
[TBL] [Abstract][Full Text] [Related]
10. The Transcription Factors PU.1 and IRF4 Determine Dendritic Cell-Specific Expression of RALDH2.
Yashiro T; Yamaguchi M; Watanuki Y; Kasakura K; Nishiyama C
J Immunol; 2018 Dec; 201(12):3677-3682. PubMed ID: 30413670
[TBL] [Abstract][Full Text] [Related]
11. The hematopoietic transcription factor PU.1 regulates RANK gene expression in myeloid progenitors.
Kwon OH; Lee CK; Lee YI; Paik SG; Lee HJ
Biochem Biophys Res Commun; 2005 Sep; 335(2):437-46. PubMed ID: 16083856
[TBL] [Abstract][Full Text] [Related]
12. Balance of MafB and PU.1 specifies alternative macrophage or dendritic cell fate.
Bakri Y; Sarrazin S; Mayer UP; Tillmanns S; Nerlov C; Boned A; Sieweke MH
Blood; 2005 Apr; 105(7):2707-16. PubMed ID: 15598817
[TBL] [Abstract][Full Text] [Related]
13. Reciprocal roles for CCAAT/enhancer binding protein (C/EBP) and PU.1 transcription factors in Langerhans cell commitment.
Iwama A; Osawa M; Hirasawa R; Uchiyama N; Kaneko S; Onodera M; Shibuya K; Shibuya A; Vinson C; Tenen DG; Nakauchi H
J Exp Med; 2002 Mar; 195(5):547-58. PubMed ID: 11877478
[TBL] [Abstract][Full Text] [Related]
14. An IRF1-IRF4 Toggle-Switch Controls Tolerogenic and Immunogenic Transcriptional Programming in Human Langerhans Cells.
Davies J; Vallejo AF; Sirvent S; Porter G; Clayton K; Qumbelo Y; Stumpf P; West J; Gray CM; Chigorimbo-Murefu NTL; MacArthur B; Polak ME
Front Immunol; 2021; 12():665312. PubMed ID: 34211464
[TBL] [Abstract][Full Text] [Related]
15. PU.1 acts as tumor suppressor for myeloma cells through direct transcriptional repression of IRF4.
Ueno N; Nishimura N; Ueno S; Endo S; Tatetsu H; Hirata S; Hata H; Matsuoka M; Mitsuya H; Okuno Y
Oncogene; 2017 Aug; 36(31):4481-4497. PubMed ID: 28368411
[TBL] [Abstract][Full Text] [Related]
16. PU.1 level-directed chromatin structure remodeling at the Irf8 gene drives dendritic cell commitment.
Schönheit J; Kuhl C; Gebhardt ML; Klett FF; Riemke P; Scheller M; Huang G; Naumann R; Leutz A; Stocking C; Priller J; Andrade-Navarro MA; Rosenbauer F
Cell Rep; 2013 May; 3(5):1617-28. PubMed ID: 23623495
[TBL] [Abstract][Full Text] [Related]
17. PU.1 and multiple IFN regulatory factor proteins synergize to mediate transcriptional activation of the human IL-1 beta gene.
Marecki S; Riendeau CJ; Liang MD; Fenton MJ
J Immunol; 2001 Jun; 166(11):6829-38. PubMed ID: 11359842
[TBL] [Abstract][Full Text] [Related]
18. Distinct regulatory networks control the development of macrophages of different origins in zebrafish.
Yu T; Guo W; Tian Y; Xu J; Chen J; Li L; Wen Z
Blood; 2017 Jan; 129(4):509-519. PubMed ID: 27940477
[TBL] [Abstract][Full Text] [Related]
19. PU.1 and IRF8 Modulate Activation of NLRP3 Inflammasome
Yashiro T; Yamamoto M; Araumi S; Hara M; Yogo K; Uchida K; Kasakura K; Nishiyama C
Front Immunol; 2021; 12():649572. PubMed ID: 33897697
[TBL] [Abstract][Full Text] [Related]
20. The hematopoietic cell-specific transcription factor PU.1 is critical for expression of CD11c.
Yashiro T; Kasakura K; Oda Y; Kitamura N; Inoue A; Nakamura S; Yokoyama H; Fukuyama K; Hara M; Ogawa H; Okumura K; Nishiyama M; Nishiyama C
Int Immunol; 2017 Feb; 29(2):87-94. PubMed ID: 28338898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
